What is Parexel's business focus and history?
Parexel is a leading global clinical research organization (CRO) based in Raleigh, North Carolina, founded in 1982 by Josef von Rickenbach and Anne B. Sayigh. It provides comprehensive clinical research and consulting services to the life sciences industry. Parexel has raised $8.5 billion in funding and employs over 24,000 professionals worldwide. The company has numerous competitors in the CRO industry, including companies like ICON plc, PPD, and Covance.
Parexel Corporate Details & Core Services
Parexel is a leading global clinical research organization (CRO) providing insights-driven clinical and consulting solutions to the world’s life sciences industry. With over 24,000 professionals worldwide, Parexel partners with biopharmaceutical leaders, emerging innovators, and sites to design and deliver clinical trials with patients in mind, broadening access and making clinical research a care option for anyone, anywhere.
Parexel Contact Information & Official Links
Website https://www.parexel.com
Social
Phone number +1 919 544 3170
Head office address Raleigh, North Carolina, United States
Tags
Clinical Research Organization
Biopharmaceutical Services
Clinical Trials
Regulatory Consulting
Medical Communications
What are Parexel's Key Business Metrics & Stats?
No of employees 24000
Founded year 1982
Type private
Industry Clinical Research
Location Raleigh, North Carolina, United States
Parexel
Firmographic Snapshot
2026
1982
Founded Year
24000
Global Employees
United States
Headquarters
Clinical Research Industry
Private
Type
Verified by
DexterAgent.ai
How much funding has Parexel raised to date?
Name
Description
Funding Amount
USD 8.5 Billion
Stage
Acquisition
Latest Valuation
8.5 Billion (USD)
Lead Investor
EQT Private Equity
Investors
EQT Private Equity, Goldman Sachs Asset Management
What are Parexel's Core Products?
Name
Description
Clinical Trial Management
Comprehensive management of Phase I-IV clinical trials across various therapeutic areas.
Regulatory Consulting
Expert guidance on regulatory strategy, submissions, compliance, and outsourcing.
Real World Evidence
Generation of real-world data to support product value and market access.
Medical Communications
Development of scientific content and communication strategies for healthcare audiences.
What are the latest developments at Parexel?
Date
Type
Description
September, 2025
Partnership
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
July, 2021
Acquisition
Parexel to be Acquired by EQT Private Equity and Goldman Sachs Asset Management
What industry awards and recognitions has Parexel received?
Date
Type
Description
December, 2025
Industry Award
Best Contract Research Organization – Full-Service Provider at the 21st annual Scrip Awards
December, 2024
Industry Award
Innovative Approaches to Patient-Centric Research at the 2024 Fierce Biotech CRO Awards
What are Parexel's official legal and registration details?
Name
Description
Legal Name
Parexel International Corporation
Cin number
GST number
Registration number
Who is in Parexel's executive leadership team?
Name
Designation
CEO
Peyton Howell
Chief Financial Officer
Simon Harford
Where are Parexel's primary office locations?
City
Country
Durham
United States
Nottingham
United Kingdom
Tokyo
Japan
Shanghai
China
Bangalore
India
What are the current business signals and market intelligence for Parexel?
Type of customer
Biopharmaceutical Companies, Biotech Firms, Medical Device Companies
Key customer domain
What is Parexel's annual revenue history?
Year
Revenue (USD)
2017
2.3 Billion
What are Parexel's risk management and compliance ratings?
GDPR RIsk
No
Privacy Risk
No
Company Ratings
Glassdoor Rating
Saas
No
Offline Stores
No
Service
Yes
Ecommerce
No
Exporter
No
Mobile App
No
Retail
No
B2B
Yes
B2C
No
Manufacturing
No
Wholesale
No
Importer
No
